Candinil 50 mg/5 ml (Powder for Suspension)
35 ml bottle: ৳ 78.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Fluconazole |
| Company | Healthcare pharmaceuticals ltd |
| Also available as |
Indications
- Vaginal Candidiasis
- Oropharyngeal Candidiasis
- Oesophageal Candidiasis
- Tinea Corporis
- Tinea Cruris
- Tinea Pedis
- Kerion
- Pityriasis Versicolor
- Onychomycosis
- Invasive Candidal Infections
- Cryptococcal Infections
- Prevention of Cryptococcal Meningitis
- Prevention of Fungal Infections in Immunocompromised Patients
- Systemic Candidiasis
- Fungal Urinary Tract Infections
- Disseminated Candidiasis
- Prophylaxis for Fungal Infection in Neutropenic Cancer Patients
- Acute Treatment of Other Systemic Fungal Infections
Pharmacology
Triazole antifungal agent, inhibitor of fungal cytochrome P-450 dependent enzymes
Dosage & Administration
- Adults dosage for different conditions
- Child dosage for specific conditions
- Dosage in specific population like elderly, renal impairment, and children
Interaction
- Interaction with warfarin
- Interaction with oral sulphonyl ureas
- Interaction with hydrochlorothiazide
- Interaction with phenytoin
- Interaction with rifampicin
- Interaction with oral contraceptives
- Interaction with cyclosporin
- Interaction with cimetidine, antacids, and total body irradiation
- Interaction with theophylline
Contraindications
Not to be used in patients with known hypersensitivity to Fluconazole or related triazole compounds
Side Effects
- Common side effects such as symptoms associated with the gastrointestinal tract
- Rare adverse events like rash
- Rare cases of anaphylaxis
Pregnancy & Lactation
Adverse fetal effects seen in animals, not recommended in pregnancy or in women of childbearing potential unless adequate contraception is employed.
Precautions & Warnings
- Observation of abnormalities of hepatic, renal, haematological, and other biochemical function tests
- Rare occurrences of hepatic necrosis
- Rare development of exfoliative cutaneous reactions
- Monitoring and discontinuation of therapy in case of rash development
- Not recommended for use in nursing mothers
- Unlikely to impair a patient's ability to drive or use machinery
Use in Special Populations
- Use in the elderly
- Use in renal impairment
Overdose Effects
Supportive measures and symptomatic treatment recommended, forced volume diuresis and haemodialysis may aid in elimination
Therapeutic Class
Drugs for subcutaneous and mycoses
Storage Conditions
Keep in a dry place away from light and heat, out of the reach of children